The goal of this study was to assess the impact of doxycycline PEP on M genitalium, an emerging pathogen among men who have sex with men that has rising rates of antibiotic resistance.
The Visby Medical Sexual Health Test showed excellent agreement with other FDA-approved laboratory-based assays.
The approval of Cabenuva was based on data from two phase 3 trials which included 1182 HIV-infected adults who were virologically suppressed (HIV-1 RNA less than 50 copies/mL) prior to initiation.
Investigators examined incidence, clearance, and risk factors for 13 high-risk human papilloma virus types in gay and bisexual men with HIV.
A group of researchers provides guidance for diagnosing and treating syphilis, especially for pregnant women who can spread the infection to the fetus.
Clinicians must consider patient sexual history in the decision-making process for adult HPV vaccination.
The USPSTF recommends behavioral counseling interventions for preventing sexually transmitted infections in adolescents and adults at increased risk.
For gonorrhea patients, detection of the wild-type serine 91 genotype of the gyrA gene of Neisseria gonorrhoeae is predictive of successful treatment with ciprofloxacin.
In an American Academy of Pediatrics policy statement, published online in Pediatrics, updated recommendations are presented relating to use of barrier methods for adolescents engaging in sexual activity.
The FDA has approved an expanded indication for Gardasil 9® (human papillomavirus 9-valent vaccine [HPV], recombinant; Merck) to include the prevention of oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58 in patients aged 9 to 45 years.
